$0.002 0.0 9.5%
Last Trade - 05/03/21
| Market Cap | ÂŁ358k |
| Enterprise Value | ÂŁn/a |
| Revenue | ÂŁn/a |
| Position in Universe | th / 6651 |
| Industry | Market | |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
| Year End 01st Jan | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020E | 2021E | CAGR / Avg | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |||||
|
x
|
||||||||||
| Profitability | ||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
|
%
|
||||||||||
| Cashflow | ||||||||||
| Dividends | ||||||||||
| Balance Sheet | ||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
|
m
|
||||||||||
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing % | |||
| Net Gearing % | |||
| Cash / Assets % |
| Liquidity (ttm) | ||
|---|---|---|
| Curr. Ratio | ||
| Quick Ratio | ||
| Interest Cov. | ||
| Efficiency (ttm) | ||
|---|---|---|
| Asset Turnover | ||
| Recs Turnover | ||
| Stock Turnover | ||
| Latest interim period vs. prior period | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
| 3yr Compound Annual Growth Rate | Industry | Market |
|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
Revenue
Net Income
Normalised EPS
PE Ratio Range
Dividend Yield Range
|
Price Target:
( below Price)
|
31st Dec 2021
|
31st Dec 2022
|
||||
|---|---|---|---|---|---|---|
| Est. Long Term Growth Rate: |
Net Profit () |
EPS () |
DPS () |
Net Profit () |
EPS () |
DPS () |
| Consensus Estimate | ||||||
| 1m Change | ||||||
| 3m Change | ||||||
Biomagnetics Diagnostics Corporation is an advanced medical device and biotechnology company. The Company’s diagnostics system focuses on real-time testing for the actual presence of the virus or toxin or disease itself and not for antibodies produced by the body's immune system which may take anywhere from weeks to months to appear. The Company’s products include High Throughput Screening - Magnetic Testing Platform (HTS-MTP) and Integrity Optical Biosensor (IOBS). Its HTS-MTP is designed to detect both qualitative chemical identification of the elements present in a substance and quantitative number of specific elements in a substance results from a single test. The Company triggered optical biosensor that is based on protein-receptor binding that brings two or more optically tagged receptors into close proximity using planar optical waveguides, thereby triggering fluorescence changes identified almost instantly by tiny on-board detectors.
| Last Annual | January 1st, 1970 |
| Last Interim | January 1st, 1970 |
| Incorporated | February 26, 1997 |
| Public Since | November 3, 1994 |
| No. of Shareholders: | n/a |
| No. of Employees: | n/a |
| Sector | Healthcare |
| Industry | Healthcare Equipment & Supplies |
| Index | |
| Exchange | Pink Sheets on Nasdaq |
| Shares in Issue | |
| Free Float | (0.0%) |
| Eligible for |
ISAs
SIPPs
|
As of 05/03/21, shares in Biomagnetics Diagnostics are trading at $0.002, giving the company a market capitalisation of ÂŁ358k. This share price information is delayed by 15 minutes.
Shares in Biomagnetics Diagnostics are currently trading at $0.002 and the price has moved by 53.33% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Biomagnetics Diagnostics price has moved by 19.66% over the past year.
There are no analysts currently covering Biomagnetics Diagnostics.
It is not known when Biomagnetics Diagnostics will next release financial results.
Biomagnetics Diagnostics does not currently pay a dividend.
Biomagnetics Diagnostics does not currently pay a dividend.
Biomagnetics Diagnostics does not currently pay a dividend.
To buy shares in Biomagnetics Diagnostics you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
Shares in Biomagnetics Diagnostics are currently trading at $0.002, giving the company a market capitalisation of ÂŁ358k.
Here are the trading details for Biomagnetics Diagnostics:
We were not able to load our ranking data for Biomagnetics Diagnostics
We were not able to load any forecast data for Biomagnetics Diagnostics.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Biomagnetics Diagnostics. Over the past six months, the relative strength of its shares against the market has been -43.02%. At the current price of $0.002, shares in Biomagnetics Diagnostics are trading at -13.69% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
We were not able to find PE ratio data for Biomagnetics Diagnostics.
Biomagnetics Diagnostics's management team is headed by:
Here are the top five shareholders of Biomagnetics Diagnostics based on the size of their shareholding:
